Journals
Publish with us
Publishing partnerships
About us
Blog
Tuberculosis Research and Treatment
Journal overview
For authors
For reviewers
For editors
Table of Contents
Special Issues
Tuberculosis Research and Treatment
/
2013
/
Article
/
Tab 2
/
Research Article
Evaluation of MGIT 960 System for the Second-Line Drugs Susceptibility Testing of
Mycobacterium tuberculosis
Table 2
Drug concentrations tested in MGIT 960 and L-J proportion method.
Drug
Concentration evaluated (
μ
g/mL)
MGIT960
L-J
Moxifloxacin
0.25, 0.5, 1.0, 2.0, 4.0
2.0
Levofloxacin
0.25, 0.5, 1.0, 2.0, 4.0, 8.0
2.0
Kanamycin
0.625, 1.25, 2.5, 5.0, 6.0, 10.0
40.0
Capreomycin
0.625, 1.25, 2.5, 5.0
40.0
Ethionamide
0.625, 1.25, 2.5, 5.0
40.0
ρ
-aminosalicylic acid
0.5, 1.0, 2.0, 4.0, 8.0, 16.0
1.0